Objective To evaluate the safety and short-term outcomes of preterm neonates born at 34-35
weeks gestation with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic …

Objective To review developmental outcomes of neonates with mild hypoxic-ischemic
encephalopathy (HIE) treated with therapeutic hypothermia (TH). Study Design Neonates≥ …

In this article, we review the childhood outcomes of neonates with birth depression and/or
hypoxic-ischemic encephalopathy. The outcomes of these children prior to the era of …

Background Therapeutic hypothermia reduces the risk of death, or moderate to severe
neurodevelopmental impairment (NDI) in term infants with hypoxic-ischemic …

Objective This study was aimed to describe utilization of therapeutic hypothermia (TH) in
neonates presenting with mild hypoxic-ischemic encephalopathy (HIE) and associated …

Objective To compare the characteristics and outcomes of neonates with mild hypoxic-
ischemic encephalopathy (HIE) who received hypothermia versus standard care. Study …

Hypoxic ischemic encephalopathy (HIE) remains a significant cause of mortality and long-
term disability in late preterm and term infants. Mild therapeutic hypothermia to a rectal …

Objective To establish the evidence of therapeutic hypothermia for newborns with hypoxic
ischemic encephalopathy (HIE). Data Sources Cochrane Central Register of Controlled …

Objectives To systematically review the effectiveness, as determined by survival without
moderate to severe neurodevelopmental disability in infancy and childhood, and the safety …

Therapeutic hypothermia holds promise as a rescue neuroprotective strategy for hypoxic-
ischemic injury, but the incidence of severe neurologic sequelae with hypothermia is …